EZEremei Zota

Eremei Zota

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eremei Zota has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Modern Therapeutic Approaches in Stroke - The Experience of the Republic of Moldova

    by Stanislav Groppa, Natalia Ciobanu, Daniela Efremova, Diana Gavriluta, Ecaterina Turcan, Diana Manea, Igor Crivorucica, Eremei Zota

    Stroke is a major public health problem both globally and in the Republic of Moldova, where incidence and mortality have been consistently higher than the European average. The evolution of the stroke healthcare service in the Republic of Moldova represents an example of systemic transformation, based on collaboration between clinicians, researchers, authorities and international partners. The creation of the national network of stroke centers, the significant increase in thrombolysis and thrombus extraction rates, as well as the reduction of critical intervention times, reflect premises for improving patient prognosis and reducing the socio-economic impact of this devastating pathology.

  • Open Access

    Particularități histopatologice și evaluarea imunohistochimică a procesului de invazivitate în endometrioza extragenitală

    by Eremei Zota, Claudiu Mărgăritescu, Eugeniu Cazacu

    The SDF-1/CXCR4 axis plays a crucial role in the invasion and metastatic processes of many human cancers. We are interested in investigating the involvement of this axis in the development of extragenital endometriosis, given its potential to influence the invasive behavior of endometrial tissue. This research could provide new insights into disease mechanisms and identify new targets for treatment. SDF-1 and CXCR4 protein expression was evaluated by immunohistochemistry in 43 cases of endometriosis and in 6 cases of normal endometrial tissues. SDF-1 and CXCR4 proteins were expressed both in endometriosis lesions and in glandular epithelial cells and mesenchymal cells of normal endometrial tissue. Positive staining was localized to the cytoplasm. A specific value was used to calculate and analyze the intensity of immunohistochemical expression. The expressions of these two proteins in endometriosis lesions were significantly higher compared with those in normal endometrial tissues, and the differences were statistically significant (P<0.05). Both markers, SDF-1 and its receptor CXCR4, were more highly expressed in endometriosis lesions compared with normal endometrial tissue. SDF-1, through its interaction with the CXCR4 receptor, plays a significant role in the pathogenesis of endometriosis by contributing to the proliferation process of endometrial stromal cells.

  • Open Access

    Features of epithelial-mesenchymal transition in ectopic endometrium in patients with extragenital endometriosis of various localizations. Observational study

    by Eugeniu Cazacu, Eremei Zota, Mariam A. Vardanyan, Radu Niguleanu, Ruslan Pretula, Aleksandra V. Asaturova, Larisa S. Ezhova, Alina S. Badlaeva, Казаку Евгений

    Background. Epithelial-mesenchymal transition (EMT) is a conserved mechanism in the process of morphogenesis and organogenesis. EMT provides cells with migratory and invasive properties, which is a necessary condition for the formation of endometrioid heterotopias. Aim. To confirm the presence of EMT features in different types of endometriosis. Materials and methods. During a period of five years (2012–2017) we analyzed 43 cases of extragenital endometriosis: appendix (3 case), colon (5 cases), ileum (1 case), abdominal scar endometriosis after caesarean section (24 cases), and inguinal hernia (10 cases). The material was processed according to histological and immunohistochemical technique using monoclonal E-cadherin and polyclonal Vimentin antibodies to assess local invasiveness. Results. In peritoneal endometriosis, the ratio of E-cadherin to Vimentin expression was 10.3, in the colon = 9.1, in the appendix 8.6, in the ileum 5.5, in the hernial sac 4.2. Thus, in diffuse infiltrative forms of endometriosis, the lesion phenotype is characterized by low expression of E-cadherin, while expression of Vimentin is at a high level (p0.05). Conclusion. The results of our study confirmed involvement of the epithelial-mesenchymal transition process in the pathogenesis of extragenital endometriosis lesions, on the one hand, and they certify its invasive potential in these localizations, on the other hand.

  • Benign prostatic hyperplasia - etiology, clinical features and management. Historical and contemporary aspects

    by Victor Bobu, Adrian Tanase, Eremei Zota

    Introduction. Benign prostatic hyperplasia and chronic prostatitis are the most common conditions in men, the frequency of which varies with age. Chronic prostatitis (infectious or inflammatory) has a frequency of 8-35% in patients aged 20-50 years, reaching a maximum of 60-70% in those aged over 50 years. Materials and methods. Materials for the study served the medical literature regarding benign prostatic hyperplasia and chronic inflammation, published in the local and international scientific journals. Scientific databases like Cochrane Library, Medline, Scopus, Medicus, NCBI, PubMed, Google Scholar were used to find the necessary articles. Research methods – analysis, synthesis, systematization, and description. Results. After analyzing the available data, a review of the literature was conducted which highlighted both the strong and weak points of the historical medical approaches to addressing benign prostatic hyperplasia, as well as the ontogenetics and anatomical characteristics of the prostate gland. This included examining the incidence rates, concepts of causation and development, principles of diagnosis and classification of benign prostatic hyperplasia. The review also revealed the pros and cons of using mini-invasive treatment strategies versus traditional transvesical approaches in treating this condition, as well as the ongoing and significant socioeconomic impact in underdeveloped countries. Conclusions. There remains the issue of reducing intra- and post-operative complications after benign prostatic hyperplasia surgery, especially a voluminous one, which imposes itself as a very critical problem in the development of an effective treatment strategy. For the first time, a problem was described by assessing the particularities of some biochemical criteria at local surgical site and in blood serum, histological - at the level of nodular prostatic hyperplasia and at the border of the surgical site. This requires a complex correlational study to assess the biochemical, histological and immunohistochemical parameters, including the evaluation of the associations or coexistence of benign prostatic hyperplasia and chronic prostatitis.


  • Six years’ experience of participation of the Institute of Emergency Medicine from Chisinau, Republic of Moldova in the Registry of Stroke Care Quality

    by Stanislav Groppa, Natalia Ciobanu, Igor Crivorucica, Eremei Zota, Sorin Plotnicu, Irina Smetanca

    Background. The Institute of Emergency Medicine from Chisinau has joined the Registry of Stroke Care Quality (RES-Q) in 2017. Material and Methods. We have analyzed the stroke patients’ data introduced in RES-Q between 20172022. Baseline characteristics, stroke-related factors, processes of care, and discharge destination were examined. Results. Data were available for 489 stroke patients. The proportion of patients with ischemic strokes receiving thrombolysis therapy has substantially increased from 2.78% in 2017 to 20% in 2022, and the median door-toneedle time decreased from 85 minutes (2017) to 48 minutes (2021). Thrombectomy began to be performed in 2018 at the Institute of Emergency Medicine, the rate of stroke patients receiving thrombectomy increased from 3.23% in 2019 to 10% in 2022, median door-to-groin time decreased from 228.5 minutes in 2019 to 102 minutes in 2021. More than 80% of patients received secondary prevention therapies that were level-1 evidence-based processes of care: antihypertensive agents (89.47% – 98.44%), antiplatelet drugs (81.63% – 100%), anticoagulants for patients with atrial fibrillation (25% in 2018 vs 100% in 2021), but cholesterol-lowering medication was prescribed to approximately a half of the participants (44.23% – 60.0%). There were more deaths in the pandemic years (36.67% in 2021 vs 18.99% in 2017). Conclusion. Most hospitalized stroke patients admitted to the Institute of Emergency Medicine received evidence-based care. The COVID-19 pandemic has left its mark on the number of stroke hospitalizations, but the quality of in-hospital stroke care was not dramatically affected.

  • Stroke care indicators in the Republic of Moldova – the RES-Q registry

    by Elena Manole, Cristina Tiu, Aleksandras Vilionskis, Alexander Tsiskaridze, Eremei Zota, Andreea Grecu, Robert Mikulik, Natan Bornstein, Stanislav Groppa

    Introduction. There were no data on in-hospital stroke care indicators until Moldova’s accession to the international Registry of Stroke Care Quality (RES-Q) platform in 2016. The aim of this paper was to assess the acute stroke care quality in Moldova based on the data of the RES-Q registry. Material and methods. We analyzed the data of all patients with acute ischemic and hemorrhagic stroke of the RES-Q from 15 Moldovan hospitals. Data were collected for one month each year, during a 3-year period (2017-2019). Data analysis was performed between hospitals according to their access to a brain CT facility for Moldovan participating hospitals. Additionally, Moldovan data were compared with other three ESO-EAST (European Stroke Organization Enhancing and Accelerating Stroke Treatment) project countries: Romania, Lithuania, and Georgia. Results. A total of 1660 patients were recruited in the study, mean age of 68 years (49% men). Moldova registered poorer results in number of brain CT performed (81% [95% CI 79-84%]), dysphagia screening (29% [95% CI 27-32%]), IV thrombolysis performed (3% [95% CI 2-4%]), administration of anticoagulants (44% [95% CI 39-49%]) and statins (42% [95% CI 39-45%]) at discharge, in-hospital stroke mortality (17% [95% CI 15- 19%]). Within Moldova the stroke care quality was driven by the access to CT scan. Conclusions. Our study highlighted some serious gaps of in-hospital stroke care performance in Moldova, such as the lack of CT scans in many public hospitals, the absence of a national stroke center network, extremely low accessibility of IV thrombolysis and unsatisfactory implementation of secondary stroke prevention treatment